Your browser doesn't support javascript.
loading
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.
Morris, Joel; Kunkel, Mark W; White, Stephen L; Wishka, Donn G; Lopez, Omar D; Bowles, Lori; Sellers Brady, Penny; Ramsey, Patricia; Grams, Julie; Rohrer, Tiffany; Martin, Karen; Dexheimer, Thomas S; Coussens, Nathan P; Evans, David; Risbood, Prabhakar; Sonkin, Dmitriy; Williams, John D; Polley, Eric C; Collins, Jerry M; Doroshow, James H; Teicher, Beverly A.
Afiliación
  • Morris J; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Kunkel MW; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • White SL; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Wishka DG; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Lopez OD; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Bowles L; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Sellers Brady P; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Ramsey P; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Grams J; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Rohrer T; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Martin K; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Dexheimer TS; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Coussens NP; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Evans D; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland.
  • Risbood P; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Sonkin D; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Williams JD; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Polley EC; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Collins JM; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
  • Teicher BA; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.
Mol Cancer Ther ; 22(11): 1270-1279, 2023 Nov 01.
Article en En | MEDLINE | ID: mdl-37550087
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article